The expression levels of ribosome biogenesis-associated genes were significantly higher in TNBC than in all other molecular breast cancer subtypes, including luminal A, luminal B and HER2-enriched (ANOVA, p = 2.79 × 10–53; Fig. 1A). The gene discussed is ERBB2; the disease is breast carcinoma.